C57BL/6N-Atm1Brd Clpptm1a(EUCOMM)Wtsi/WtsiH

Status

Available to order

EMMA IDEM:09701
International strain nameC57BL/6N-Atm1Brd Clpptm1a(EUCOMM)Wtsi/WtsiH
Alternative nameEPD0665_3_D05
Strain typeTargeted Mutant Strains
Allele/Transgene symbolClpptm1a(EUCOMM)Wtsi
Gene/Transgene symbolClpp
DisclaimerPlease note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
  1. We can not guarantee a null mutation for Knock-out first alleles (tm1a alleles, see http://www.mousephenotype.org/about-ikmc/targeting-strategies) as the critical exon has not been deleted.
  2. That the structure of the targeted mutation in the ES cells obtained from EUCOMM/KOMP to generate EUCOMM/KOMP mice is not verified by INFRAFRONTIER/EMMA. It is recommended that the recipient confirms the mutation structure.
  3. No check for determining the copy number of the targeting construct in ES cells obtained from EUCOMM/KOMP is done by INFRAFRONTIER/EMMA.
  4. The level of quality control before mice are released is to confirm the individual mouse genotype by short range PCR.

Information from provider

Provider Wellcome Trust Sanger Institute
Provider affiliationWellcome Trust Sanger Institute
Genetic informationThis mouse line originates from EUCOMM ES clone EPD0665_3_D05. For further details on the construction of this clone see the page at the IMPC portal.
Phenotypic informationPotential phenotyping data in the IMPC portal
ReferencesNone available

Information from EMMA

Archiving centreMary Lyon Centre at MRC Harwell, Oxford, United Kingdom

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (allele matching)
  • decreased bone mineral density / IMPC
  • increased leukocyte cell number / IMPC
  • increased monocyte cell number / IMPC
  • tremors / IMPC
  • decreased body length / IMPC
  • male infertility / IMPC
  • female infertility / IMPC
  • increased hematocrit / IMPC
  • increased circulating serum albumin level / IMPC
  • increased circulating alkaline phosphatase level / IMPC
  • thrombocytopenia / IMPC
  • increased circulating glycerol level / IMPC
  • abnormal bone structure / IMPC
  • increased lean body mass / IMPC
  • decreased lean body mass / IMPC
  • abnormal auditory brainstem response / IMPC
  • increased B cell number / IMPC
  • increased circulating cholesterol level / IMPC
  • increased circulating aspartate transaminase level / IMPC
  • increased circulating bilirubin level / IMPC
  • decreased circulating glucose level / IMPC
  • increased mean corpuscular hemoglobin / IMPC
  • increased hemoglobin content / IMPC
  • decreased NK T cell number / IMPC
  • increased mature B cell number / IMPC
  • decreased gamma-delta T cell number / IMPC
  • increased circulating iron level / IMPC
  • increased total body fat amount / IMPC
  • decreased total body fat amount / IMPC
  • decreased red blood cell distribution width / IMPC
  • decreased circulating fructosamine level / IMPC
  • decreased bone mineral content / IMPC
  • decreased effector memory CD8-positive, alpha-beta T cell number / IMPC
  • increased KLRG1-positive NK cell number / IMPC
  • increased Ly6C high monocyte number / IMPC
  • increased Ly6C low monocyte number / IMPC
  • decreased memory-marker CD4-negative NK T cell number / IMPC
  • decreased CD4-positive NK T cell number / IMPC
  • decreased memory-marker CD4-positive NK T cell number / IMPC
IMPC phenotypes (gene matching)
  • thrombocytopenia / IMPC
  • increased circulating bilirubin level / IMPC
  • decreased lean body mass / IMPC
  • increased leukocyte cell number / IMPC
  • increased circulating cholesterol level / IMPC
  • increased mean corpuscular hemoglobin / IMPC
  • increased monocyte cell number / IMPC
  • increased Ly6C low monocyte number / IMPC
  • decreased bone mineral content / IMPC
  • decreased circulating fructosamine level / IMPC
  • increased lean body mass / IMPC
  • increased KLRG1-positive NK cell number / IMPC
  • increased circulating glycerol level / IMPC
  • decreased total body fat amount / IMPC
  • decreased NK T cell number / IMPC
  • decreased memory-marker CD4-positive NK T cell number / IMPC
  • decreased body length / IMPC
  • increased hemoglobin content / IMPC
  • increased total body fat amount / IMPC
  • increased mature B cell number / IMPC
  • decreased bone mineral density / IMPC
  • decreased circulating glucose level / IMPC
  • increased circulating serum albumin level / IMPC
  • increased B cell number / IMPC
  • abnormal bone structure / IMPC
  • tremors / IMPC
  • increased circulating iron level / IMPC
  • decreased effector memory CD8-positive, alpha-beta T cell number / IMPC
  • abnormal auditory brainstem response / IMPC
  • increased Ly6C high monocyte number / IMPC
  • female infertility / IMPC
  • decreased CD4-positive NK T cell number / IMPC
  • decreased red blood cell distribution width / IMPC
  • increased circulating aspartate transaminase level / IMPC
  • increased hematocrit / IMPC
  • decreased memory-marker CD4-negative NK T cell number / IMPC
  • increased circulating alkaline phosphatase level / IMPC
  • male infertility / IMPC
  • decreased gamma-delta T cell number / IMPC
MGI phenotypes (gene matching)
  • decreased cell proliferation / MGI
  • small ovary / MGI
  • small testis / MGI
  • arrest of spermatogenesis / MGI
  • dermatitis / MGI
  • decreased body length / MGI
  • hypoactivity / MGI
  • decreased startle reflex / MGI
  • abnormal T cell activation / MGI
  • male infertility / MGI
  • female infertility / MGI
  • abnormal oogenesis / MGI
  • premature death / MGI
  • decreased corpora lutea number / MGI
  • decreased vertical activity / MGI
  • azoospermia / MGI
  • early cellular replicative senescence / MGI
  • abnormal granulosa cell morphology / MGI
  • decreased susceptibility to weight gain / MGI
  • abnormal cellular respiration / MGI
  • preweaning lethality, incomplete penetrance / MGI
  • increased mitochondria size / MGI
  • disorganized mitochondrial cristae / MGI
  • abnormal mitochondrial chromosome morphology / MGI
  • abnormal seminiferous tubule epithelium morphology / MGI
  • increased embryonic tissue cell apoptosis / MGI
  • increased granulosa cell apoptosis / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
MTA will be issued after an order has been submitted.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).